You have 9 free searches left this month | for more free features.

Condition

Castration-Resistant Prostatic Cancer (1)

Metastatic Castration-Resistant Prostate Cancer (1)

Overall Status

Available (1)

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Lantheus Medical Imaging (1)

POINT Biopharma (1)

Collaborator

POINT Biopharma (1)

Intervention

[lu-177]-pnt2002 (2)

abiraterone (1)

enzalutamide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Expanded Access (1)

Interventional (1)

[lu-177]-pnt2002

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available

Castration-Resistant Prostatic Cancer

[Lu-177]-PNT2002

(no location specified)

Sep 11, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide ([Lu-177]-PNT2002, Abiraterone, Enzalutamide)

Recruiting

Metastatic Castration-Resistant Prostate Cancer

[Lu-177]-PNT2002
+2 more

Tucson, Arizona
+47 more

Jun 1, 2022